A Study of Molidustat for Maintenance Treatment of Renal Anemia in Non-dialysis Subjects
Status:
Completed
Trial end date:
2019-11-28
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of molidustat in
non-dialysis subjects previously treated with Erythropoiesis-Stimulating Agents (ESAs)